Cargando…
Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells
The lack of effective treatments for mitochondrial disease has seen the development of new approaches, including those that aim to stimulate mitochondrial biogenesis to boost ATP generation above a critical disease threshold. Here, we examine the effects of the peroxisome proliferator-activated rece...
Autores principales: | Burgin, Harrison J., Lopez Sanchez, M. Isabel G., Smith, Craig M., Trounce, Ian A., McKenzie, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139379/ https://www.ncbi.nlm.nih.gov/pubmed/32244971 http://dx.doi.org/10.3390/ijms21062139 |
Ejemplares similares
-
Stimulating Mitochondrial Biogenesis with Deoxyribonucleosides Increases Functional Capacity in ECHS1-Deficient Cells
por: Burgin, Harrison James, et al.
Publicado: (2022) -
Peptide-mediated delivery of donor mitochondria improves mitochondrial function and cell viability in human cybrid cells with the MELAS A3243G mutation
por: Chang, Jui-Chih, et al.
Publicado: (2017) -
Nitric Oxide Synthesis Is Increased in Cybrid Cells with m.3243A>G Mutation
por: Gamba, Juliana, et al.
Publicado: (2012) -
Gastrointestinal Involvement in m.3243A>G-associated MELAS
por: Finsterer, Josef, et al.
Publicado: (2017) -
Impact of Mitochondrial A3243G Heteroplasmy on Mitochondrial Bioenergetics and Dynamics of Directly Reprogrammed MELAS Neurons
por: Lin, Dar-Shong, et al.
Publicado: (2022)